PAQR7 and lung adenocarcinoma: The results of this study also showed that P4/Org treatment can also inhibit the PKA/CREB pathway in mPRα knockdown lung adenocarcinoma cells, suggesting that other receptors were involved in addition to the mPRα‐mediated effects in this process.